Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
4
Neutral
2
Bullish
8
Bearish
36
Neutral
2
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Upcoming Result Date: Nov 05, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q1 FY26
Sampre Nutritions Ltd (SAMPRE) is currently trading at 4.20 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Sampre Nutritions Ltd. specializes in manufacturing sugar candies, including various branded products like Dairy Milk Eclairs and jelly cups. The company serves notable clients such as Cadbury India Ltd (now Mondelez India Foods) and has a strong contract manufacturing presence. In 2022, Sampre Nutritions expanded its production capacity, becoming the exclusive partner for Mondelez India for Eclairs in both domestic and export markets, bolstering its strategic positioning. The establishment of subsidiaries in Dubai and the UK in 2023 signals Sampre Nutritions’ ambition to expand internationally, aiming to capture more global confectionery market share. The company’s history reflects strategic moves with major industry players like Indian Airlines, showcasing a proven ability to secure significant partnerships. Sampre Nutritions has demonstrated adaptability by expanding its product range under its own brand in recent years, indicating an initiative to strengthen brand recognition and consumer engagement.
Over the past 52 weeks, Sampre Nutritions Ltd has traded between a low of ₹4.16 and a high of ₹38.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Sampre Nutritions Ltd has a market capitalization of approximately 39.90. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Sampre Nutritions Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 12.13 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 39.90 Cr, Sampre Nutritions Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Sampre Nutritions Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Sampre Nutritions Ltd is 12.13. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Sampre Nutritions Ltd. specializes in manufacturing sugar candies, including various branded products like Dairy Milk Eclairs and jelly cups. The company serves notable clients such as Cadbury India Ltd (now Mondelez India Foods) and has a strong contract manufacturing presence.
In 2022, Sampre Nutritions expanded its production capacity, becoming the exclusive partner for Mondelez India for Eclairs in both domestic and export markets, bolstering its strategic positioning.
The establishment of subsidiaries in Dubai and the UK in 2023 signals Sampre Nutritions’ ambition to expand internationally, aiming to capture more global confectionery market share.
The company’s history reflects strategic moves with major industry players like Indian Airlines, showcasing a proven ability to secure significant partnerships.
Sampre Nutritions has demonstrated adaptability by expanding its product range under its own brand in recent years, indicating an initiative to strengthen brand recognition and consumer engagement.
Food Products
Packaged Foods
40 Cr
Low Risk
12.1
39.2
0.1
0.4
38.95
4.16
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
15.70 | 44 Cr | 129.06 | 2.70 | 0.00 | 6.01 | 9.20 | 0.87 | ||
28.25 | 42 Cr | 10.36 | 0.87 | 0.00 | 8.43 | 9.29 | 3.73 | ||
100.40 | 40 Cr | -13.22 | 2.55 | 0.00 | 3.53 | 4.73 | 3.14 | ||
4.20 | 40 Cr | 12.13 | 0.37 | 0.00 | 2.87 | 2.51 | 2.66 | ||
40.85 | 38 Cr | 5.35 | 1.11 | 0.00 | 32.29 | 30.77 | 0.00 | ||
23.00 | 38 Cr | -26.26 | 0.61 | 0.00 | -2.31 | 1.22 | -0.97 | ||
7.12 | 36 Cr | 46.13 | 0.77 | 0.00 | 3.23 | 5.45 | 2.73 | ||
| Median: 7 Co. | — | 23.00 | 40 Cr | 10.36 | 0.87 | 0.00 | 3.53 | 5.45 | 2.66 |
